Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19

NCT06311435 is registered in ClinicalTrials.gov with MaxWell Clinic, PLC as lead sponsor.

NCT NCT06311435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06311435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
Lead sponsor
MaxWell Clinic, PLC
Phase
Not applicable
Overall status
Recruiting
Start date
March 15, 2024
Completion date
March 15, 2026
Enrollment
224 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

long covid